Reason: CGMP Deviations: OTC products were stored outside of labeled temperature requirements.
Distributed: Nationwide in the USAReason: Failed Dissolution Specifications
Distributed: Nationwide in the USA.Reason: Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
Distributed: Product was distributed to physician's offices nationwide.Reason: Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).
Distributed: Nationwide in the US.Reason: Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
Distributed: Nationwide in the USAReason: Subpotent: Failing Test Results for Epinephrine
Distributed: NationwideReason: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
Distributed: Nationwide in the USAReason: Failed Dissolution Specifications
Distributed: Nationwide in the USA.Reason: Non-Sterility
Distributed: Nationwide and UK, Canada, Italy, India, Australia, Germany, Switzerland, Singapore, Netherlands, Ireland, South Korea, Belgium, Norway, Saudi- Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, Barbados.Reason: CGMP Deviations
Distributed: Nationwide and UK, Canada, Italy, India, Australia, Germany, Switzerland, Singapore, Netherlands, Ireland, South Korea, Belgium, Norway, Saudi- Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, Barbados.